[go: up one dir, main page]

AU2736600A - Control of virus infection using replication associated proteins, compositions and methods of use - Google Patents

Control of virus infection using replication associated proteins, compositions and methods of use

Info

Publication number
AU2736600A
AU2736600A AU27366/00A AU2736600A AU2736600A AU 2736600 A AU2736600 A AU 2736600A AU 27366/00 A AU27366/00 A AU 27366/00A AU 2736600 A AU2736600 A AU 2736600A AU 2736600 A AU2736600 A AU 2736600A
Authority
AU
Australia
Prior art keywords
compositions
methods
control
virus infection
associated proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27366/00A
Inventor
Anju Chatterji
Claude Fauquet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU2736600A publication Critical patent/AU2736600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/12011—Geminiviridae
    • C12N2750/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU27366/00A 1999-01-26 2000-01-27 Control of virus infection using replication associated proteins, compositions and methods of use Abandoned AU2736600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11728599P 1999-01-26 1999-01-26
US60117285 1999-01-26
PCT/US2000/001849 WO2000043494A2 (en) 1999-01-26 2000-01-27 Control of virus infection using replication associated proteins, compositions and methods of use

Publications (1)

Publication Number Publication Date
AU2736600A true AU2736600A (en) 2000-08-07

Family

ID=22372016

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27366/00A Abandoned AU2736600A (en) 1999-01-26 2000-01-27 Control of virus infection using replication associated proteins, compositions and methods of use

Country Status (4)

Country Link
EP (1) EP1147177A4 (en)
AU (1) AU2736600A (en)
MX (1) MXPA01007582A (en)
WO (1) WO2000043494A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920000D0 (en) * 1999-08-25 1999-10-27 Imp Cancer Res Tech Polypeptides
CA2446643A1 (en) 2001-05-07 2002-11-14 Jane E. Polston Materials and methods for producing tomato yellow leaf curl virus resistance in plants
US8901372B2 (en) 2009-02-25 2014-12-02 University Of Hawaii Plant resistance to banana bunchy top virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997039110A1 (en) * 1996-04-16 1997-10-23 Seminis Vegetable Seeds, Inc. Transgenic plants expressing geminivirus genes

Also Published As

Publication number Publication date
WO2000043494A3 (en) 2000-11-30
EP1147177A2 (en) 2001-10-24
WO2000043494A2 (en) 2000-07-27
MXPA01007582A (en) 2003-06-24
WO2000043494A9 (en) 2001-08-09
EP1147177A4 (en) 2005-03-16

Similar Documents

Publication Publication Date Title
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU1436401A (en) RepO-associated virus AAV REP78 major regulatory protein, mutants thereof and uses thereof
AU3730600A (en) Compositions preparations and uses of human papillomavirus l1 protein
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU2002220460A1 (en) The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU2281601A (en) Treatment of viral infections using levovirinTM
AU4985596A (en) Novel aroylaniline derivatives, compositions and uses thereof in the treatment of viral infections
AU2002324753A1 (en) Composition and method for treating viral infection
AU2525701A (en) Derivatives of quinazolinedione phthalimide, preparations thereof and their therapeutic uses
AU2736600A (en) Control of virus infection using replication associated proteins, compositions and methods of use
AU6846500A (en) Novel 8-carbonyl chroman derivatives, preparation and therapeutic use thereof
AU6901000A (en) Bioartificial device for propagation of tissue, preparation and uses thereof
AU2002364696A1 (en) Crystalline neutrokine-alpha protein, method of preparation thereof, and method of use thereof
AU2001297575A1 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU2002332613A1 (en) Compositions and therapeutic methods for viral infection
AU2002327531A1 (en) Therapeutic compositions and methods for treating viral infection
AU2001273245A1 (en) Modulators of trk protein activity, compositions and uses
AU2002213259A1 (en) Egf motif protein, egfl6 materials and methods
AU2002217863A1 (en) Homing peptide multimers, their preparation and uses
AU2001237518A1 (en) Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application
AU2526001A (en) 2-phenyl-quinoline derivatives, preparation method and therapeutic use thereof
AU3971800A (en) 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase